| scholarly article | Q13442814 |
| P2093 | author name string | Lina Xu | |
| Yan Qi | |||
| Jinyong Peng | |||
| Lianhong Yin | |||
| Xufeng Tao | |||
| Lisha Zhao | |||
| P2860 | cites work | The role of sirtuins in cardiac disease | Q27693274 |
| The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia | Q28271441 | ||
| Cardiomyocyte autophagy and cancer chemotherapy | Q33573823 | ||
| Cardiotoxicity of doxorubicin and other anthracycline derivatives | Q33852542 | ||
| Total Flavonoids from Clinopodium chinense (Benth.) O. Ktze Protect against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo | Q35136498 | ||
| MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity | Q35274471 | ||
| High Throughput Screening Identifies a Novel Compound Protecting Cardiomyocytes from Doxorubicin-Induced Damage | Q35681478 | ||
| MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction | Q35763090 | ||
| Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway | Q36361268 | ||
| Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging | Q36451899 | ||
| Doxorubicin in experimental and clinical heart failure | Q36562427 | ||
| Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes | Q36620605 | ||
| Anthracycline associated cardiotoxicity in survivors of childhood cancer | Q37112428 | ||
| Dioscin-induced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines | Q37300056 | ||
| Regulation of myocardial growth and death by NADPH oxidase | Q37826870 | ||
| A new insight into adriamycin-induced cardiotoxicity | Q38012571 | ||
| Emerging role of microRNAs in cardiovascular diseases. | Q38187516 | ||
| Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. | Q38431346 | ||
| miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204. | Q38669417 | ||
| Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation | Q38721587 | ||
| miR-140-5p regulates adipocyte differentiation by targeting transforming growth factor-β signaling | Q38812460 | ||
| miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. | Q38841797 | ||
| Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone. | Q38876257 | ||
| Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway | Q38922785 | ||
| Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70. | Q38966339 | ||
| Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts | Q39065082 | ||
| Dioscin prevents the mitochondrial apoptosis and attenuates oxidative stress in cardiac H9c2 cells | Q39109682 | ||
| Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities | Q39972544 | ||
| Targeting MicroRNA Function in Acute Pancreatitis | Q41978704 | ||
| The antifungal activity and membrane-disruptive action of dioscin extracted from Dioscorea nipponica | Q42713709 | ||
| Anti-thrombotic activity and chemical characterization of steroidal saponins from Dioscorea zingiberensis C.H. Wright | Q42957763 | ||
| Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats. | Q43166156 | ||
| Emodin Alleviates Sodium Taurocholate-Induced Pancreatic Acinar Cell Injury via MicroRNA-30a-5p-Mediated Inhibition of High-Temperature Requirement A/Transforming Growth Factor Beta 1 Inflammatory Signaling | Q43795438 | ||
| Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice | Q45853133 | ||
| Diallyl trisulfide suppresses doxorubicin-induced cardiomyocyte apoptosis by inhibiting MAPK/NF-κB signaling through attenuation of ROS generation | Q46271795 | ||
| MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. | Q47204916 | ||
| CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1. | Q47603462 | ||
| Propofol alleviates liver oxidative stress via activating Nrf2 pathway | Q47718195 | ||
| Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation | Q47805474 | ||
| Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease | Q47908768 | ||
| Protective effects of dioscin against cisplatin-induced nephrotoxicity via the microRNA-34a/sirtuin 1 signalling pathway. | Q48131275 | ||
| Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition | Q48280594 | ||
| Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo. | Q52840605 | ||
| Quantitative chemical proteomics for investigating the biomarkers of dioscin against liver fibrosis caused by CCl4 in rats. | Q53469990 | ||
| Doxorubicin-induced cardiomyopathy | Q77323607 | ||
| The role of COX-2 and Nrf2/ARE in anti-inflammation and antioxidative stress: Aging and anti-aging | Q84001359 | ||
| Circulating microRNAs as Biomarkers in Cardiovascular Diseases | Q86809686 | ||
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 189-198 | |
| P577 | publication date | 2018-03-06 | |
| P1433 | published in | Redox Biology | Q27724751 |
| P1476 | title | Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. | |
| P478 | volume | 16 |
| Q60937783 | Dioscin Inhibits Virulence Factors of |
| Q64930303 | Downregulation of miR-130a, antagonized doxorubicin-induced cardiotoxicity via increasing the PPARγ expression in mESCs-derived cardiac cells. |
| Q59127640 | Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects |
| Q64100444 | Neuroprotective Effect of Dioscin on the Aging Brain |
| Q90400038 | Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb Signal |
| Q90070027 | Recent Advances in the Pharmacological Activities of Dioscin |
| Q90469804 | Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine |
| Q90421154 | The Effects of Inhibition of MicroRNA-375 in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity |
| Q59327156 | The Role of Natural Products in Targeting Cardiovascular Diseases via Nrf2 Pathway: Novel Molecular Mechanisms and Therapeutic Approaches |
| Q59795304 | miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3 |
| Q90448502 | miR-140-5p mediates bevacizumab-induced cytotoxicity to cardiomyocytes by targeting the VEGFA/14-3-3γ signal pathway |
Search more.